Pacira BioSciences (PCRX) Cash & Equivalents (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Cash & Equivalents of $144.3 million for Q1 2026, down 49.12% year-over-year from $283.6 million in Q1 2025, and down 8.98% quarter-over-quarter from $158.5 million in Q4 2025.
Pacira BioSciences (PCRX) Cash & Equivalents (2010 - 2026) Analysis & Trends
Pacira BioSciences' Cash & Equivalents history runs 17 years deep, the most recent figure standing at $144.3 million for Q1 2026.
- In Q1 2026, Cash & Equivalents fell 49.12% year-over-year to $144.3 million; the TTM figure through Mar 2026 stood at $144.3 million (down 49.12% YoY), while the FY2025 annual figure was $158.5 million, down 42.72% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $144.3 million, down from $158.5 million in the prior quarter.
- The five-year high for Cash & Equivalents was $300.5 million in Q2 2025, with the low at $35.5 million in Q1 2023.
- The 5-year median for Cash & Equivalents is $153.3 million (2023), against an average of $172.1 million.
- The sharpest annual moves came in 2023 and 2024: Cash & Equivalents tumbled 84.32% in 2023, then soared 417.8% in 2024.
- Pacira BioSciences' Cash & Equivalents stood at $104.1 million in 2022, then surged by 47.21% to $153.3 million in 2023, then soared by 80.55% to $276.8 million in 2024, then slumped by 42.72% to $158.5 million in 2025, then fell by 8.98% to $144.3 million in 2026.
- Business Quant data shows PCRX's Cash & Equivalents at $144.3 million in Q1 2026, $158.5 million in Q4 2025, and $147.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 164.00 Mn |
| 10 | Pacira BioSciences | 944.33 Mn | 693.29 Mn | 148.24 Mn | 205.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 205.88 Mn |
| Mar 31, 2026 | 144.31 Mn |
| Dec 31, 2025 | 158.55 Mn |
| Sep 30, 2025 | 147.59 Mn |
| Jun 30, 2025 | 300.48 Mn |
| Mar 31, 2025 | 283.61 Mn |
| Dec 31, 2024 | 276.77 Mn |
| Sep 30, 2024 | 245.97 Mn |
| Jun 30, 2024 | 247.05 Mn |
| Mar 31, 2024 | 184.05 Mn |
| Dec 31, 2023 | 153.30 Mn |
| Sep 30, 2023 | 99.12 Mn |
| Jun 30, 2023 | 86.81 Mn |
| Mar 31, 2023 | 35.55 Mn |
| Dec 31, 2022 | 104.14 Mn |
| Sep 30, 2022 | 109.42 Mn |
| Jun 30, 2022 | 122.06 Mn |
| Mar 31, 2022 | 226.75 Mn |
| Dec 31, 2021 | 585.58 Mn |
| Sep 30, 2021 | 134.04 Mn |